The effect of pentoxifylline on chronic venous ulcers

Wounds

Volumn 24, Issue 7, 2012, Pages 190-194

  Parsa, Hossien ^a   Zangivand, Amir Abdollah ^a   Hajimaghsoudi, Liela ^a  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864398285     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines of assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130:489-493.
2. Ibrahim S, MacPherson DR, Goldhaber SZ. Chronic venous insufficiency: mechanisms and management. Am Heart J. 1996;132(4):856-860.
3. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed). 1988;1296:1726-1727.
4. Stücker M, Reich S, Robak-Pawelczyk B, et al. Changes in venous refilling time from childhood to adulthood in subjects with apparently normal veins. J Vasc Surg. 2005;41(2):296-302.
5. Trent JT, Falabella A, Eaglstein WH, Kirsner RS. Venous ulcers: pathophysiology and treatment options. Ostomy Wound Manage. 2005;51(5):38-56.
6. Colgan MP, Dormandy JA, Jones PW, Schraibman IG, Shanik DG, Young RA. Oxpenifylline treatment of venous ulcers of the leg. BMJ. 1990;300:972-975.
7. Layton AM, Ibbotson SH, Davies JA, Goodfield MJ. Randomised trial of oral aspirin for chronic venous leg ulcers. Lancet. 1994;344(8916):164-165.
8. Puchmayer V. Modern therapeutic trends in the conservative treatment of ischemic disease of lower extremities. Vnitr Lek. 1995(3);41:204-206.
9. Angelkort B, Kiesewetter H. Influence of risk factors and coagulation on the fluidity of blood in chronic arterial occlusive disease. Scand J Clin Lab Invest. 1981;41(Suppl 156):185-188.
10. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol. 1994;30(4):603-621.
11. Ambrus J, Stadler S, Kulaylat M. Hemorrhagic effects of metabolites of pentoxifylline (Trental). J Med. 1995;26:65-75.
12. Belacro G, Cesarone MR, Nicolaides AN, et al. Treatment of venous ulcers with pentoxifylline: a 6-month, randomized double-blind, placebo-controlled trial. Angiology. 2002;53:45-47.
13. Chibnall JT, Tait RC. Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales. Pain. 2001;92:173-186.
14. Brodovicz KG, McNaughton K, Uemura N, et al. Reliability and feasibility of methods to quantitatively assess peripheral edema. Clin Med Res. 2009;7:21-31.
15. Frampton JE, Brogden RN. Pentoxifylline (Oxpentifylline): a review of its therapeutic efficacy in the management of peripheral, vascular and cerebrovascular disorders. Drugs Aging. 1995;7(6):480-503.
16. Falanga V, Fujitani RM, Diaz C, et al. Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial. Wound Repair Regen. 1999;7:208-213.
17. De Sanctis MT, Cesarone MR, Belcaro G, et al. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial-walking distance and microcirculation. Angiology. 2002;53(Suppl 1):S7-12.
18. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet. 2002;359:1550-1554.
19. Chatle TR, Scott HJ, Scurr JH, Coleridge Smith PD. White cell, skin blood flow and venous ulcers. BR J Dermatol. 1991;125:288-290.